Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK ( TheStreet) -- With just three trading days left in the quarter, Jim Cramer told his "Mad Money" viewers Thursday that the age-old tradition of money managers padding their portfolios with the "anointed" hot stocks for the year has begun.
With a government shutdown looming, Cramer said the following 10 stocks can be bought on weakness heading into the end of the year.
Cramer previously highlighted the first four names on the list, the biotech giants that every money manager has to show they own: Biogen Idec (BIIB), Celgene (CELG), Regeneron (REGN) and Gilead Sciences (GILD).Next on the list is LinkedIn (LNKD), the only social networking company with accelerating revenue growth that continues to surprise Wall Street. Then there are the "cult" stocks of Amazon.com (AMZN), Netflix (NFLX) and Tesla Motors (TSLA). Cramer said these three stocks have valuations that defy logic, but no one seems to care. Last on the list are Priceline.com (PCLN) and Facebook (FB), a stock Cramer owns for his charitable trust,